CDK1 Human shRNA Plasmid Kit (Locus ID 983)
CDK1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
|Product Name||CDK1 Human shRNA Plasmid Kit (Locus ID 983)|
|Synonyms||CDC28A; CDK1; DKFZp686L20222; MGC111195|
|E. coli Selection||Chloramphenicol|
|Kit Components||CDK1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 983). 5µg purified plasmid DNA per constructNon-effective 29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free.|
|RefSeq||NM_001130829, NM_001170406, NM_001170407, NM_001786, NM_033379, NM_001320918, NM_001786.1, NM_001786.2, NM_001786.3, NM_001786.4, NM_033379.1, NM_033379.2, NM_033379.3, NM_033379.4, NM_001170406.1, NM_001170407.1, NM_001130829.1, BC014563, BC014563.1, BC107750, NM_001786.5|
|Summary||The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is a catalytic subunit of the highly conserved protein kinase complex known as M-phase promoting factor (MPF), which is essential for G1/S and G2/M phase transitions of eukaryotic cell cycle. Mitotic cyclins stably associate with this protein and function as regulatory subunits. The kinase activity of this protein is controlled by cyclin accumulation and destruction through the cell cycle. The phosphorylation and dephosphorylation of this protein also play important regulatory roles in cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]|
|shRNA Design||These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact firstname.lastname@example.org. If you need a special design or shRNA sequence, please utilize our custom shRNA service.|
|Performance Guaranteed||OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at email@example.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.